Estrella Immunopharma Analyst Price Targets

Wall Street analyst price targets and consensus rating for Estrella Immunopharma (ESLA).

Price Target Range — 5 Quarters

Analyst Consensus — 1 Analysts

1Buy

Consensus RatingBuy# Analysts1Avg. Consensus PT$8Upside to Avg. PT+1472.3%

Rating Trend — Last 9 Months

Recent Analyst Actions

すべての評価を見る →

Date	Firm	Analyst	Action	Rating Change	Price Target
Feb 9, 2026	D. Boral Capital	Jason Kolbert	Maintained	Buy	$8
Jan 28, 2026	D. Boral Capital	Jason Kolbert	PT Cut	Buy	$16→$8
Nov 3, 2025	D. Boral Capital	Jason Kolbert	Maintained	Buy	$16
Aug 12, 2025	D. Boral Capital	Jason Kolbert	Maintained	Buy	$16
Jun 3, 2025	D. Boral Capital	Jason Kolbert	Maintained	Buy	$16
May 29, 2025	D. Boral Capital	Jason Kolbert	Maintained	Buy	$16
Feb 21, 2025	D. Boral Capital	Jason Kolbert	Maintained	Buy	$16
Feb 18, 2025	D. Boral Capital	Jason Kolbert	Initiate	Buy	$16

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
D. Boral Capital Maintains Buy on Estrella Immunopharma, Maintains $8 Price Target

D. Boral Capital analyst Jason Kolbert maintains Estrella Immunopharma (NASDAQ:ESLA) with a Buy and maintains $8 price target.

Benzinga Newsdesk

PRO
D. Boral Capital Maintains Buy on Estrella Immunopharma, Lowers Price Target to $8

D. Boral Capital analyst Jason Kolbert maintains Estrella Immunopharma (NASDAQ:ESLA) with a Buy and lowers the price target from $16 to $8.

Benzinga Newsdesk

PRO
D. Boral Capital Maintains Buy on Estrella Immunopharma, Maintains $16 Price Target

D. Boral Capital analyst Jason Kolbert maintains Estrella Immunopharma (NASDAQ:ESLA) with a Buy and maintains $16 price target.

Benzinga Newsdesk

PRO
D. Boral Capital Maintains Buy on Estrella Immunopharma, Maintains $16 Price Target

D. Boral Capital analyst Jason Kolbert maintains Estrella Immunopharma (NASDAQ:ESLA) with a Buy and maintains $16 price target.

Benzinga Newsdesk

PRO
D. Boral Capital Maintains Buy on Estrella Immunopharma, Maintains $16 Price Target

D. Boral Capital analyst Jason Kolbert maintains Estrella Immunopharma (NASDAQ:ESLA) with a Buy and maintains $16 price target.

Benzinga Newsdesk

PRO
D. Boral Capital Maintains Buy on Estrella Immunopharma, Maintains $16 Price Target

D. Boral Capital analyst Jason Kolbert maintains Estrella Immunopharma (NASDAQ:ESLA) with a Buy and maintains $16 price target.

Benzinga Newsdesk

Estrella Immunopharma Inc

ニュース

パートナーシップ

ベンジンガ・グローバル

Estrella Immunopharma Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
D. Boral Capital Maintains Buy on Estrella Immunopharma, Maintains $8 Price Target

PRO
D. Boral Capital Maintains Buy on Estrella Immunopharma, Lowers Price Target to $8

PRO
D. Boral Capital Maintains Buy on Estrella Immunopharma, Maintains $16 Price Target

PRO
D. Boral Capital Maintains Buy on Estrella Immunopharma, Maintains $16 Price Target

PRO
D. Boral Capital Maintains Buy on Estrella Immunopharma, Maintains $16 Price Target

PRO
D. Boral Capital Maintains Buy on Estrella Immunopharma, Maintains $16 Price Target

People Also Watch

People Also Watch

Estrella Immunopharma Inc

ニュース

パートナーシップ

ベンジンガ・グローバル

Estrella Immunopharma Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROD. Boral Capital Maintains Buy on Estrella Immunopharma, Maintains $8 Price Target

PROD. Boral Capital Maintains Buy on Estrella Immunopharma, Lowers Price Target to $8

PROD. Boral Capital Maintains Buy on Estrella Immunopharma, Maintains $16 Price Target

PROD. Boral Capital Maintains Buy on Estrella Immunopharma, Maintains $16 Price Target

PROD. Boral Capital Maintains Buy on Estrella Immunopharma, Maintains $16 Price Target

PROD. Boral Capital Maintains Buy on Estrella Immunopharma, Maintains $16 Price Target

People Also Watch

People Also Watch

PRO
D. Boral Capital Maintains Buy on Estrella Immunopharma, Maintains $8 Price Target

PRO
D. Boral Capital Maintains Buy on Estrella Immunopharma, Lowers Price Target to $8

PRO
D. Boral Capital Maintains Buy on Estrella Immunopharma, Maintains $16 Price Target

PRO
D. Boral Capital Maintains Buy on Estrella Immunopharma, Maintains $16 Price Target

PRO
D. Boral Capital Maintains Buy on Estrella Immunopharma, Maintains $16 Price Target

PRO
D. Boral Capital Maintains Buy on Estrella Immunopharma, Maintains $16 Price Target